About GenePOC Diagnostics
GenePOC Diagnostics is a company based in Quebec City (Canada) founded in 2007 was acquired by Meridian Bioscience in April 2019. GenePOC Diagnostics operates in a competitive market with competitors including Prenetics, Karius, Day Zero Diagnostics, OpGen and Clear Labs, among others.
- Headquarter Quebec City, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Meridian Bioscience
& 2 more
-
Employee Count
Not available
-
Acquired by
Meridian Bioscience
(Apr 30, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of GenePOC Diagnostics
Investors in GenePOC Diagnostics
GenePOC Diagnostics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Meridian Bioscience, Debiopharm and Credit Mutuel Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and VC investments are directed toward multiple sectors.
|
Locked | Locked | Locked | |
|
Biopharmaceutical company focused on oncology, infectious diseases, and orphan drugs
|
Locked | Locked | Locked | |
|
Molecular diagnostic device and kits
|
Locked | Locked | Locked |
Investor details for GenePOC Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GenePOC Diagnostics
Investment portfolio details for GenePOC Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GenePOC Diagnostics
Detailed financials for GenePOC Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genepoc Diagnostics Comparisons
Peer comparison for GenePOC Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GenePOC Diagnostics
GenePOC Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Karius, Day Zero Diagnostics, OpGen and Clear Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Food safety technologies are provided for pathogen identification.
|
|
| Locked | Locked | Locked |
Viral infection treatments are developed using nucleic acid hybrid chemistry.
|
Detailed competitors of GenePOC Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genepoc Diagnostics
Complete news archive for GenePOC Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GenePOC Diagnostics
GenePOC Diagnostics was founded in 2007 and raised its 1st funding round 8 years after it was founded.
GenePOC Diagnostics is headquartered in Quebec City, Canada. It is registered at Quebec City, Quebec, Canada.
GenePOC Diagnostics was founded in 2007 in Quebec City, Canada, within the diagnostics sector. Rapid nucleic acid assays for infectious diseases are created for point-of-care use. An automated device is employed, in which a small patient sample is loaded onto a cartridge and inserted into a reader for digital results within one hour. Development focuses on tests for STDs, hospital-acquired infections, respiratory conditions, neonatal sepsis, and gastrointestinal infections.
GenePOC Diagnostics's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
GenePOC Diagnostics has 3 investors. Key investors include Meridian Bioscience, Debiopharm, and Credit Mutuel Equity.